Study to Assess the Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of GW003 in Patients With Breast Cancer

NCT02725606 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Chemotherapy-induced Neutropenia

Interventions

BIOLOGICAL: Pegylated Recombinant Human G-CSF
BIOLOGICAL: GW003

Sponsor

Jiangsu T-Mab Biopharma Co.,Ltd